![Michael Taylor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Taylor
Président chez Mitokinin, Inc.
Postes actifs de Michael Taylor
Sociétés | Poste | Début | Fin |
---|---|---|---|
Cequent Pharmaceuticals, Inc.
![]() Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - | - |
Mission Biocapital (California)
![]() Mission Biocapital (California) Investment ManagersFinance BioInnovation LLC is a Angel firm, a subsidiary of BioInnovation LLC founded in 2018. BioInnovation LLC is headquartered in Cambridge. | Corporate Officer/Principal | - | - |
Telo Therapeutics, Inc.
![]() Telo Therapeutics, Inc. BiotechnologyHealth Technology Telo Therapeutics, Inc. develops precision medicines to reverse cancer cell immortality. | Directeur/Membre du Conseil | - | - |
Mitokinin, Inc.
![]() Mitokinin, Inc. BiotechnologyHealth Technology Mitokinin, Inc. develops kinase neo-substrates for the treatment of neurodegenerative and mitochondrial diseases. The company was founded by Kevan Shokat, Nicholas Hertz, and Daniel de Roulet Jr. and is headquartered in New York, NY. | Président | - | - |
BioInnovation Management LLC
![]() BioInnovation Management LLC Investment ManagersFinance BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D Parker and Susie T Harborth. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01/01/2020 | - |
Historique de carrière de Michael Taylor
Anciens postes connus de Michael Taylor
Sociétés | Poste | Début | Fin |
---|---|---|---|
DECIPHERA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/03/2014 | 23/06/2021 |
Directeur Général | 01/03/2014 | 18/03/2019 | |
President | 01/03/2014 | 18/03/2019 | |
Ensemble Therapeutics Corp.
![]() Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/07/2007 | 01/10/2013 |
Directeur Général | 01/07/2007 | 01/10/2013 | |
President | 01/07/2007 | 01/10/2013 | |
ADHERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 26/07/2010 | 22/08/2012 |
Independent Dir/Board Member | 11/05/2011 | 22/08/2012 | |
ADHERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2010 | 01/01/2012 |
░░░░░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | ░░░░░░░░░░ |
Formation de Michael Taylor
State University of New York at Buffalo | Doctorate Degree |
University of South Florida | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 15 |
Opérationnelle
Director/Board Member | 7 |
Corporate Officer/Principal | 4 |
Chief Executive Officer | 3 |
Sectorielle
Health Technology | 8 |
Consumer Services | 4 |
Finance | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
PFIZER, INC. | Health Technology |
ADHERA THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 9 |
---|---|
Ensemble Therapeutics Corp.
![]() Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Process Industries |
Cequent Pharmaceuticals, Inc.
![]() Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Health Technology |
Deciphera Pharmaceuticals LLC
![]() Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
BioInnovation Management LLC
![]() BioInnovation Management LLC Investment ManagersFinance BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D Parker and Susie T Harborth. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Warner-Lambert Co. LLC | |
Deciphera Pharmaceuticals, Inc.
![]() Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
Mitokinin, Inc.
![]() Mitokinin, Inc. BiotechnologyHealth Technology Mitokinin, Inc. develops kinase neo-substrates for the treatment of neurodegenerative and mitochondrial diseases. The company was founded by Kevan Shokat, Nicholas Hertz, and Daniel de Roulet Jr. and is headquartered in New York, NY. | Health Technology |
Telo Therapeutics, Inc.
![]() Telo Therapeutics, Inc. BiotechnologyHealth Technology Telo Therapeutics, Inc. develops precision medicines to reverse cancer cell immortality. | Health Technology |
Mission Biocapital (California)
![]() Mission Biocapital (California) Investment ManagersFinance BioInnovation LLC is a Angel firm, a subsidiary of BioInnovation LLC founded in 2018. BioInnovation LLC is headquartered in Cambridge. | Finance |
- Bourse
- Insiders
- Michael Taylor
- Expérience